Clinical Trials

90 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05951179 2026-05-18

ADVANCED-2

131 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT06929286 2026-05-11

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

125 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05126472 2026-05-08

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

55 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05316155 2026-05-08

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

235 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06319820 2026-05-08

MoonRISe-1

641 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06733363 2026-05-08

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

344 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06919965 2026-05-08

MoonRISe-3

220 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05796375 2026-05-04

ReplaceCysto

240 enrolled

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06637423 2026-05-01

TroFuse-027

32 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04752722 2026-04-30

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

350 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07283835 2026-04-23

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

16 enrolled

Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ

NCT07206225 2026-04-21

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

294 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07322263 2026-04-17

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

174 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT03317158 2026-04-15

ADAPT-BLADDER

55 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05483868 2026-04-15

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

55 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06503614 2026-04-08

ENHANCE

60 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07000084 2026-04-07

GAIN-BCG

330 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06833073 2026-04-06

INTerpath-011

308 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

40 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06800963 2026-03-27

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

40 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07495072 2026-03-27

PRO-GAG

56 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis, Interstitial

NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Phase 4 Recruiting

40 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06173349 2026-03-13

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

12 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06245603 2026-02-06

Hydeal Cyst

200 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07339761 2026-01-14

SPICE

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT05962541 2025-12-31

CUT-less

Phase 4 Recruiting

327 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05327647 2025-12-18

BicaBCa

160 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT03945162 2025-11-24

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

90 enrolled

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06781879 2025-10-03

COBRA-NMIBC

Phase 4 Recruiting

272 enrolled

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT07187063 2025-09-22

Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

56 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06351904 2025-09-11

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

72 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05519241 2025-09-02

A Phase I Intravesical PPM Therapy for NMIBC

29 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07122414 2025-08-14

A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

80 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07036731 2025-06-25

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

428 enrolled

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT06663137 2025-06-13

HGNMIBC

70 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07019220 2025-06-13

COBRA

47 enrolled

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT04375813 2025-05-15

eRapa

166 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06889623 2025-03-21

HIGCrecur

72 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06735287 2025-03-18

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

60 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06696794 2025-02-19

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

180 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06186414 2025-01-15

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

152 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05790850 2024-12-16

PRIMER

30 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Motor Activity

NCT04106115 2024-12-04

DURANCE

64 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06632964 2024-10-09

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

16 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05232136 2024-08-12

OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer

30 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06187506 2024-07-12

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

20 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT06287541 2024-03-01

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

428 enrolled

Non-Muscle Invasive Bladder Neoplasms, Fanconi Syndrome

NCT06241755 2024-02-05

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

412 enrolled